TYK2 in Immune Responses and Treatment of Psoriasis
Lin Shang,* Jiali Cao,* Siqi Zhao, Jingya Zhang, Yanling He Department of Dermatology, Capital Medical University Affiliated Beijing Chaoyang Hospital, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yanling He, Email heyanlin...
Main Authors: | Shang L, Cao J, Zhao S, Zhang J, He Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-09-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/tyk2-in-immune-responses-and-treatment-of-psoriasis-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Mesenchymal stem cells alleviate psoriasis-like dermatitis in mice by inhibiting TYK2 phosphorylation
by: Lina LIANG, et al.
Published: (2022-06-01) -
Discovery of WD-890: A novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases
by: Zhiqin Fang, et al.
Published: (2023-11-01) -
Molecular dissection of Janus kinases as drug targets for inflammatory diseases
by: Sunghark Kwon
Published: (2022-12-01) -
JAK inhibitors ∼ overview∼
by: Hideto Kameda
Published: (2023-07-01) -
Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism
by: Yuchen Nan, et al.
Published: (2017-12-01)